NEW YORK, September 11, 2023 — Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, today announced a new partnership with DeepIntent, a technology company with an advertising platform built purposefully for the healthcare industry.
Taboola partners with more than 9,000 publishers, reaching nearly 600 million daily active users and with today’s news, pharma advertisers partnering with DeepIntent will gain access to a diverse range of premium digital platforms, ensuring their messages are displayed in brand-safe and contextually relevant environments.
According to recent research conducted by Taboola and Kantar, native ads outperformed other channels at boosting mid-funnel KPIs and exceeded various marketing objectives, such as building brand awareness, consideration, brand favorability, and message association. With Taboola, DeepIntent’s extensive portfolio of hundreds of pharmaceutical brands and leading healthcare agencies can tap into these benefits, driving results for nearly any marketing objective.
“Surveying patients four separate times, we’ve consistently found that relevant pharma ads have the power to inspire action, whether that’s taking a healthcare provider’s advice or making an appointment to see one in the first place. More than ever before, we see and hear that healthcare marketers are craving performance from their marketing investments,” said Chris Paquette, Founder and CEO of DeepIntent. “With our pharma-specific solutions, Taboola ensures their advertisers are serving the most relevant ads, improving their bottom line while improving patient outcomes.”
Taboola powers recommendations for the open web, helping people discover things they may like.
The company’s platform, powered by artificial intelligence, is used by digital properties, including websites, devices and mobile apps, to drive monetization and user engagement. Taboola has long-term partnerships with some of the top digital properties in the world, including CNBC, BBC, NBC News, Business Insider, The Independent and El Mundo.
More than 15,000 advertisers use Taboola to reach nearly 600 million daily active users in a brand-safe environment. Following the acquisition of Connexity in 2021, Taboola is a leader in powering e-commerce recommendations, driving more than 1 million monthly transactions. Leading brands including Walmart, Macy’s, Skechers and eBay are among key customers.
Learn more at www.taboola.com and follow @taboola on Twitter.
With a core belief that advertising technology can measurably improve the lives of patients, DeepIntent is leading the healthcare advertising industry into the future. Built purposefully for the healthcare industry, the DeepIntent Healthcare Advertising Platform is proven to drive higher audience quality and script performance with patented technology and the industry’s most comprehensive health data. DeepIntent is trusted by 600+ pharmaceutical brands and all the leading healthcare agencies to reach the most relevant healthcare provider and patient audiences across all channels and devices. For more information, visit DeepIntent.com or find us on LinkedIn.